Cost-effectiveness and economic benefits of vaccines in low-and middle-income countries: a systematic review

S Ozawa, A Mirelman, ML Stack, DG Walker… - Vaccine, 2012 - Elsevier
BACKGROUND: Public health interventions that prevent mortality and morbidity have greatly
increased over the past decade. Immunization is one of these preventive interventions, with …

Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review

M Fesenfeld, R Hutubessy, M Jit - Vaccine, 2013 - Elsevier
Abstract The World Health Organization recommends establishing that human
papillomavirus vaccination is cost-effective before vaccine introduction. We searched …

[PDF][PDF] Disease control priorities in developing countries

G Alleyne, J Breman, M Claeson, D Evans, D Jamison… - 2006 - researchonline.lshtm.ac.uk
Each product of the Disease Control Priorities Project marries economic approaches with
those of epidemiology, public health, and clinical medicine. While general lessons emerge …

[HTML][HTML] Malaria surveillance—United States, 2015

KE Mace - MMWR. Surveillance Summaries, 2018 - cdc.gov
Abstract Problem/Condition: Malaria in humans is caused by intraerythrocytic protozoa of the
genus Plasmodium. These parasites are transmitted by the bite of an infective female …

[PDF][PDF] WHO guide for standardization of economic evaluations of immunization programmes

World Health Organization - 2019 - apps.who.int
This guide was developed to help meet the need of decision-makers for relevant, reliable
and consistent economic information; it aims to provide clear and concise, practical, high …

Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys

EA Burger, S Sy, M Nygård, IS Kristiansen, JJ Kim - PloS one, 2014 - journals.plos.org
Background Increasingly, countries have introduced female vaccination against human
papillomavirus (HPV), causally linked to several cancers and genital warts, but few have …

Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination

SS Ng, R Hutubessy, N Chaiyakunapruk - Vaccine, 2018 - Elsevier
Background The success of human papillomavirus (HPV) national immunization program
depends on effective strategies in optimizing the uptake of HPV vaccine. Given the …

Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review

F Marra, K Cloutier, B Oteng, C Marra, G Ogilvie - Pharmacoeconomics, 2009 - Springer
The recent approval of human papillomavirus (HPV) vaccine means that decision makers
need information beyond that available from randomized clinical trials to recommend …

The cost effectiveness of human papillomavirus vaccines: a systematic review

K Seto, F Marra, A Raymakers, CA Marra - Drugs, 2012 - Springer
Introduction: Human papillomavirus (HPV) is one of the world's most common sexually
transmitted infections, and has been associated with a number of cervical and non-cervical …

Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model

L Zhou, B Gu, J Wang, G Liu, X Zhang - BMC Public Health, 2022 - Springer
Background Human papillomavirus (HPV) vaccines have been proven effective against
cervical cancer. However, HPV vaccination is not included in the Chinese immunization …